Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8038111 | 0.85 | LMNA (0.35) | LMNA | |
| SCHEMBL7445196 | 0.77 | LMNA (0.38) | LMNACYP2C19 | |
| SCHEMBL8052781 | 0.77 | LMNA (0.45) | LMNACYP2C19 | |
| SCHEMBL8049813 | 0.76 | LMNA (0.39) | LMNACYP2C19 | |
| SCHEMBL8049787 | 0.72 | LMNA (0.42) | LMNA | |
| SCHEMBL5897536 | 0.70 | LMNA (0.60) | LMNACYP2C19 | |
| SCHEMBL4763235 | 0.69 | CYP2C19 (0.31) | LMNACYP2C19 | |
| SCHEMBL8674990 | 0.69 | LMNA (0.32) | LMNACYP2C19 | |
| SCHEMBL8049770 | 0.69 | LMNA (0.43) | LMNA | |
| SCHEMBL2384958 | 0.67 | LMNA (0.56) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0563096-B1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 2000-05-03 | — | — | EP | disclosed |
| US-5438048-A | Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation | LEIRAS OY (FI) | 1995-08-01 | — | — | US | disclosed |
| EP-0563096-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 1993-10-06 | — | — | EP | disclosed |
| WO-1992011267-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 1992-07-09 | — | — | WO | disclosed |